131 related articles for article (PubMed ID: 22683457)
1. The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief review.
Corkery JM; Durkin E; Elliott S; Schifano F; Ghodse AH
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):259-62. PubMed ID: 22683457
[TBL] [Abstract][Full Text] [Related]
2. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review.
Corkery JM; Elliott S; Schifano F; Corazza O; Ghodse AH
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):253-8. PubMed ID: 22687464
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
4. Delirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT.
Jovel A; Felthous A; Bhattacharyya A
J Forensic Sci; 2014 May; 59(3):844-6. PubMed ID: 24329118
[TBL] [Abstract][Full Text] [Related]
5. The hallucinogenic world of tryptamines: an updated review.
Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
[TBL] [Abstract][Full Text] [Related]
7. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.
Brandt SD; Kavanagh PV; Dowling G; Talbot B; Westphal F; Meyer MR; Maurer HH; Halberstadt AL
Drug Test Anal; 2017 Jan; 9(1):115-126. PubMed ID: 27100373
[TBL] [Abstract][Full Text] [Related]
8. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.
Klein LM; Cozzi NV; Daley PF; Brandt SD; Halberstadt AL
Neuropharmacology; 2018 Nov; 142():231-239. PubMed ID: 29499272
[TBL] [Abstract][Full Text] [Related]
9. Loss of Consciousness and Visual Hallucinations Related to 5-MeO-DALT Intake, a Case Report Confirmed by Toxicological Analyses.
Dufayet L; Langrand J; Alvarez JC; Islam Larabi A
J Anal Toxicol; 2022 Aug; 46(7):e186-e190. PubMed ID: 35365824
[TBL] [Abstract][Full Text] [Related]
10. MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update.
Corkery JM; Elliott S; Schifano F; Corazza O; Ghodse AH
Hum Psychopharmacol; 2013 Jul; 28(4):345-55. PubMed ID: 23881883
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
Cozzi NV; Daley PF
Bioorg Med Chem Lett; 2016 Feb; 26(3):959-964. PubMed ID: 26739781
[TBL] [Abstract][Full Text] [Related]
12. An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.
Arunotayanun W; Dalley JW; Huang XP; Setola V; Treble R; Iversen L; Roth BL; Gibbons S
Bioorg Med Chem Lett; 2013 Jun; 23(11):3411-5. PubMed ID: 23602445
[TBL] [Abstract][Full Text] [Related]
13. Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence.
Bassi M; Bilel S; Tirri M; Corli G; Di Rosa F; Gregori A; Alkilany AM; Rachid O; Roda E; Zauli G; Locatelli CA; Marti M
Psychopharmacology (Berl); 2024 Mar; 241(3):489-511. PubMed ID: 38214743
[TBL] [Abstract][Full Text] [Related]
14. Trends in DMT and other tryptamine use among young adults in the United States.
Palamar JJ; Le A
Am J Addict; 2018 Oct; 27(7):578-585. PubMed ID: 30260086
[TBL] [Abstract][Full Text] [Related]
15. First Death Involving 4-Fluoroethylphenidate (4F-EPH): Case Report, User Experiences, and Review of the Related Literature.
Corkery JM; Schifano F
Acad Forensic Pathol; 2022 Dec; 12(4):149-166. PubMed ID: 36545302
[TBL] [Abstract][Full Text] [Related]
16. 5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis.
Kalasho A; Vibe Nielsen S
Acta Anaesthesiol Scand; 2016 Oct; 60(9):1332-6. PubMed ID: 27453155
[No Abstract] [Full Text] [Related]
17. N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
Shulgin AT; Carter MF
Commun Psychopharmacol; 1980; 4(5):363-9. PubMed ID: 6949674
[No Abstract] [Full Text] [Related]
18. Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.
Fabregat-Safont D; Barneo-Muñoz M; Martinez-Garcia F; Sancho JV; Hernández F; Ibáñez M
J Chromatogr A; 2017 Jul; 1508():95-105. PubMed ID: 28602505
[TBL] [Abstract][Full Text] [Related]
19. Nontargeted metabolomic insights into the behavioral effects of 5-MeO-MiPT in zebrafish (Danio rerio).
Zhao S; Chen J; Zhong C; Meng L; Wang Y
Ecotoxicol Environ Saf; 2024 Mar; 272():116044. PubMed ID: 38295732
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
